Creator: Ukrainian Community Advisory Board (UCAB) Patients of Ukraine

Description: In 2013, due to the critical economic situation and national currency devaluation, the prices for drugs presented for state tenders were substantially raised by pharmaceutical companies by up to 300%. UCAB decided to appeal to pharmaceutical companies in an effort to end the sale unrealistically high priced medical products in Ukraine.